Surgical ablation of ventricular tachycardia in patients with repaired tetralogy of Fallot†
Author(s) -
Federica Caldaroni,
Mauro Lo Rito,
Massimo Chessa,
Alessandro Varrica,
Angelo Micheletti,
Carlo Pappone,
Alessandro Giamberti
Publication year - 2018
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezy407
Subject(s) - medicine , tetralogy of fallot , cardiology , ventricular tachycardia , radiofrequency ablation , implantable cardioverter defibrillator , catheter ablation , pulmonary valve insufficiency , atrial fibrillation , intracardiac injection , atrial flutter , pulmonary atresia , pulmonary valve , ablation , surgery , heart disease , pulmonary regurgitation
Life expectancy of patients with repaired tetralogy of Fallot is normal until adulthood, when it becomes burdened by major complications such as cardiac arrhythmias and heart failure. Ventricular tachycardia (VT), associated with electrical conduction abnormalities in anatomical isthmuses, is the most common complication and is refractory to medical therapy. The arrhythmogenic sources can be surgically ablated during reoperations for pulmonary valve incompetence. The purpose of our study is to evaluate the safety and effectiveness of surgical radiofrequency ablation during PVR and its long-term impact on the occurrence of cardiac events.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom